The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
Paper No. 34
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte W. HARRY MANDEVILLE, and STEPHEN RANDALL
__________
Appeal No. 2003-0564
Application No. 08/964,498
__________
ON BRIEF
__________
Before WILLIAM F. SMITH, SCHEINER, and GRIMES, Administrative Patent
Judges.
GRIMES, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on appeal under 35 U.S.C. § 134 from the examiner’s
final rejection of claims 9-18. Claims 1-8 and 19-28 are also pending but have
been withdrawn from consideration. See Paper No. 19, mailed Nov. 7, 2000.
Claim 9 is representative of the claims on appeal and is reproduced in an
appendix to this opinion.
1. A method for lowering the serum phosphate level of a patient
comprising administering to the patient a therapeutically
effective amount of a polymer characterized by a substituted
or unsubstituted diallylamine repeat unit.
Page: 1 2 3 4 5 6 7 8 Next
Last modified: November 3, 2007